Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine
Reference40 articles.
1. Anderson LV, Harrison RM, Pogue R et al (2000) Secondary reduction in calpain 3 expression in patients with limb-girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord 10:553–559.
2. Angelini C, Giaretta L, Marozzo R (2018) An update on diagnostic options and considerations in limb-girdle dystrophies. Expert Rev Neurother 18:693–703.
https://doi.org/10.1080/14737175.2018.1508997
3. Angelini C, Nardetto L, Borsato C, Padoan R, Fanin M, Nascimbeni AC, Tasca E (2010) The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B). Neurol Res 32:41–46.
https://doi.org/10.1179/174313209X380847
4. L Brenguier, I Richard, P Dinçer, C Roudaut, B Bady, J M Burgunder, R Chemaly, C A Garcia, G Halaby, C E Jackson, D M Kurnit, G Lefranc, C Legum, J Loiselet, L Merlini, A Nivelon-Chevallier, E Ollagnon-Roman, G Restagno, H Topaloglu, and J S Beckmann, (1997) Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet. 60(5): 1128–1138.
5. Chae J1, Minami N, Jin Y, Nakagawa M, Murayama K, Igarashi F, Nonaka I. (2001). Calpain 3 gene mutations: genetic and clinico-pathologic findings in limbgirdle muscular dystrophy. Neuromuscul Disord (6-7):547-55.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献